Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (101-110 of 323) with videos related to

Pageof 33
Sort By:
Seminars in Oncology|September 12, 2017
Corrigendum to "Tumor Macroenvironment and Metabolism" [Seminars in Oncology, Vol 41, No 2, April 2014, pp 281-295]Wael Al-Zoughbi, Jianfeng Huang, Ganapathy S Paramasivan, et al.
Urologic Oncology|July 17, 2014
Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaGeorg C Hutterer, Caroline Stoeckigt, Tatjana Stojakovic, et al.
The Journal of Urology|January 28, 2015
The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell CarcinomaAngelika Bezan, Edvin Mrsic, Daniel Krieger, et al.
World Journal of Surgical Oncology|October 18, 2015
Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literatureJoerg Lindenmann, Nicole Fink-Neuboeck, Martin Pichler, et al.
Onkologie|August 1, 2012
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 casesKonstantin Schlick, Ariane Aigelsreiter, Martin Pichler, et al.
International Urology and Nephrology|March 30, 2012
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survivalMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
The Journal of Molecular Diagnostics : JMD|January 31, 2009
High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysisMarija Balic, Martin Pichler, Jasmin Strutz, et al.
Biology|May 27, 2023
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In VitroGeorg Richtig, Melanie Kienzl, Sonja Rittchen, et al.
International Journal of Molecular Sciences|November 8, 2014
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell linesAndrej Wagner, Christian Mayr, Doris Bach, et al.
Cancer Communications (London, England)|August 20, 2024
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapiesMaxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Pageof 33

Showing results (101-110 of 323) with videos related to

Sort By:
Pageof 33
Seminars in Oncology|September 12, 2017
Corrigendum to "Tumor Macroenvironment and Metabolism" [Seminars in Oncology, Vol 41, No 2, April 2014, pp 281-295]Wael Al-Zoughbi, Jianfeng Huang, Ganapathy S Paramasivan, et al.
Urologic Oncology|July 17, 2014
Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaGeorg C Hutterer, Caroline Stoeckigt, Tatjana Stojakovic, et al.
The Journal of Urology|January 28, 2015
The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell CarcinomaAngelika Bezan, Edvin Mrsic, Daniel Krieger, et al.
World Journal of Surgical Oncology|October 18, 2015
Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literatureJoerg Lindenmann, Nicole Fink-Neuboeck, Martin Pichler, et al.
Onkologie|August 1, 2012
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 casesKonstantin Schlick, Ariane Aigelsreiter, Martin Pichler, et al.
International Urology and Nephrology|March 30, 2012
Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survivalMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
The Journal of Molecular Diagnostics : JMD|January 31, 2009
High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysisMarija Balic, Martin Pichler, Jasmin Strutz, et al.
Biology|May 27, 2023
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In VitroGeorg Richtig, Melanie Kienzl, Sonja Rittchen, et al.
International Journal of Molecular Sciences|November 8, 2014
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell linesAndrej Wagner, Christian Mayr, Doris Bach, et al.
Cancer Communications (London, England)|August 20, 2024
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapiesMaxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Pageof 33